A phase 1/1b trial of PUR1900 in healthy normal volunteers and patients with asthma
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2018
At a glance
- Drugs PUR 1900 (Primary) ; Itraconazole
- Indications Asthma; Cystic fibrosis-associated respiratory tract infections
- Focus Adverse reactions; First in man; Pharmacokinetics
- 12 Feb 2018 According to a Pulmatrix media release, first patient has been dosed in this study.
- 22 Jan 2018 According to a Pulmatrix media release, the company has begun to screen subjects and expects to initiating dosing in early February. The company expects that top line results will be available in mid-2018.
- 22 Jan 2018 Status changed from planning to recruiting, according to a Pulmatrix media release.